Stretch mark prevention product wins £400k funding

THE North West Fund for Biomedical has invested £400,500 in a company that has developed a product to prevent stretch marks during pregnancy.

Stuff of Life, which will be moving to Merseyside and creating 10 jobs over the next two years, has developed ‘Liforma’, a clinically proven preventative product to reduce the incidence of stretch marks during pregnancy.

Its ‘Total Stretch Mark Support’ system includes a stretch mark support band, worn during the day over the pregnancy bump, a day gel and a night cream.
 
The funding will be used to finalise and safeguard patents, complete regulatory work, appoint fulfilment partners and implement an online and social media strategy for the launch to women who are 12-16 weeks pregnant and healthcare professionals.

Sophie Hooper, chief executive officer at Liforma said: “We are delighted that SPARK Impact [which manages the fund] has invested in Liforma. They share the company’s belief that the product will be a ‘must have’ for every woman who is pregnant and is concerned about getting stretch marks, and fully support our go-to-market strategies in the UK and the US.”

Liforma is the 47th investment for The North West Fund for Biomedical, which is a sub-fund of The North West Fund.